Meta (Tech) trends in Pharma & Life science and what this means for CROs

Platforms have habitually disrupted unregulated industries, such as retail and tourism, but are now moving to more regulated sectors, such as finance and mobility. Healthcare is next; Digital-Health-Platforms (DHPs) are rising and will transform the way care is delivered across all dimensions (the Where, the Who, the When, and the How). 

These Digital Health Platforms are also a strategic enabler for Medical and R&D: Sanofi inked a big deal with A.I. discovery company Exscientia and AstraZeneca took stake in Huma to make clinical trials more efficient with digital technology. 

However, there is still a long way to go.